(Q43241190)

17 November 2017

title

Rapamycin as a therapy of choice after renal transplantation in a patient with tuberous sclerosis complex (English)

1 reference

Maria Alicja Dębska-Ślizień

17 November 2017

1 reference

1 reference

1 reference

series ordinal

2

object named as

A Debska-Slizień

1 reference

17 November 2017

5

B Rutkowski

1 reference

17 November 2017

A Tarasewicz

1

1 reference

17 November 2017

J Konopa

series ordinal

3

1 reference

17 November 2017

Z Zdrojewski

series ordinal

4

1 reference

17 November 2017

language of work or name

English

0 references

publication date

1 November 2009

1 reference

Transplantation Proceedings

17 November 2017

published in

1 reference

17 November 2017

volume

41

1 reference

17 November 2017

issue

9

1 reference

17 November 2017

page(s)

3677-3682

1 reference

Tuberous sclerosis complex: advances in diagnosis, genetics, and management.

17 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Tuberous sclerosis complex: genetics to pathogenesis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Tuberous sclerosis complex-1 and -2 gene products function together to inhibit mammalian target of rapamycin (mTOR)-mediated downstream signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Mutational analysis in a cohort of 224 tuberous sclerosis patients indicates increased severity of TSC2, compared with TSC1, disease in multiple organs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Possible mechanisms of disease development in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

End-stage renal failure in adults with the tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Chronic renal failure and its treatment in tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Bilateral renal angiomyolipomatosis in tuberous sclerosis presenting with chronic renal failure: case report and review of the literature

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Rapamycin causes regression of astrocytomas in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Antitumoral activity of rapamycin in renal angiomyolipoma associated with tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Management of renal angiomyolipomas associated with tuberous sclerosis complex.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

An epidemiological study of renal pathology in tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Tuberous sclerosis and the kidney: from mesenchyme to epithelium, and beyond

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Bourneville-Pringle disease for kidney transplantation: a single-center experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Anesthetic management of a patient with tuberous sclerosis presenting for renal transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Combined nephrectomy and pre-emptive renal transplantation in a tuberous sclerosis patient with angiomyolipoma, renal carcinoma and life-threatening abdominal haemorrhages

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Developing multiple lung nodules in a renal transplant recipient with tuberous sclerosis who had undergone bilateral nephrectomy due to renal cell carcinomas

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

The mTOR inhibitor rapamycin significantly improves facial angiofibroma lesions in a patient with tuberous sclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Rapamycin: an anti-cancer immunosuppressant?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

mTOR inhibition and its effect on cancer in transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Maintenance immunosuppression with target-of-rapamycin inhibitors is associated with a reduced incidence of de novo malignancies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Two-year incidence of malignancy in sirolimus-treated renal transplant recipients: results from five multicenter studies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Dramatic effect of sirolimus on renal angiomyolipomas in a patient with tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Sirolimus therapy in tuberous sclerosis or sporadic lymphangioleiomyomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Efficacy of sirolimus in treating tuberous sclerosis and lymphangioleiomyomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

7 January 2021

Lymphangioleiomyomatosis

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Lymphangioleiomyomatosis and tuberous sclerosis complex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Sirolimus treatment for pulmonary lymphangioleiomyomatosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

Lymphangioleiomyomatosis: A review

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2009.06.227

10.1016/J.TRANSPROCEED.2009.06.227

7 January 2021

Identifiers

DOI

1 reference

17 November 2017

1 reference